California Stadol Side Effects Attorneys

Stadol nasal spray, manufactured by Bristol-Myers Squibb Company was introduced to the market in 1992. One spray of Stadol is equivalent to 37.5 mg of Demerol. Originally the manufacturer promoted eighteen sprays a day as safe and effective to treat migraine pain. When Bristol-Myers Squibb Company won FDA approval to sell Stadol NS, it stated the drug would not be used chronically, meaning not for prolonged or repetitive use. Nevertheless, immediately upon its approval, the company marketed the drug aggressively for migraines, which is frequently a chronic problem requiring repetitive use. The extent of the problem is staggering. As of 1997, there had been forty-one Stadol-related deaths reported to the FDA, along with 8,000 adverse reaction and addiction reports. Since then, there have been many more reports and the problem of addiction continues. If you, or anyone you know, have suffered problems while using Stadol, you should contact one of our skilled Stadol side effect lawyers immediately to investigate your right to file suit against the manufacturer of this spray.

Back to Pharmaceutical Litigation.